Center-Authored Papers

Filters: Author is Chamberlain, Marc  [Clear All Filters]
C
Chamberlain M.  2011.  Evolving strategies: future treatment of glioblastoma.. Expert review of neurotherapeutics. 11(4):519-32. Abstract
Chamberlain M, Junck L, Brandsma D, Soffietti R, Rudà R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E et al..  2016.  Leptomeningeal metastases: a RANO proposal for response criteria.. Neuro-oncology. Abstract
Chamberlain M, Soffietti R, Raizer J, Rudà R, Brandsma D, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Junck L et al..  2014.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.. Neuro-oncology. Abstract
Chowdhary S, Chamberlain M.  2013.  Bevacizumab for the treatment of glioblastoma.. Expert review of neurotherapeutics. 13(8):937-49. Abstract
G
Grimm S, Chamberlain M.  2011.  Hodgkin's Lymphoma: A Review of Neurologic Complications.. Advances in hematology. 2011:624578. Abstract
K
Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D et al..  2014.  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.. Neuro-oncology. Abstract
Korfel A, Chamberlain M, Neuwelt E, Thiel E, Doolittle N, Schlegel U, Dreyling M, Rubenstein J, Fischer L, Björkholm M et al..  2016.  Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
N
Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J et al..  2017.  The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.. Neuro-oncology. 19(5):625-635. Abstract
R
Raizer JJ, Grimm SA, Rademaker A, Chandler JP, Muro K, Helenowski I, Rice L, McCarthy K, Johnston SK, Mrugala MM et al..  2014.  A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.. Journal of neuro-oncology. 117(1):93-101. Abstract